GoodRx Holdings, Inc.
GDRX
$2.81
-$0.02-0.71%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.47% | 0.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.47% | 0.05% | |||
| Cost of Revenue | 0.52% | -0.10% | |||
| Gross Profit | -3.75% | 0.06% | |||
| SG&A Expenses | 2.03% | 3.18% | |||
| Depreciation & Amortization | 8.63% | -5.66% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.92% | 0.62% | |||
| Operating Income | -45.47% | -3.53% | |||
| Income Before Tax | -68.84% | 17.45% | |||
| Income Tax Expenses | -26.03% | 19.91% | |||
| Earnings from Continuing Operations | -91.29% | 16.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -91.29% | 16.21% | |||
| EBIT | -45.47% | -3.53% | |||
| EBITDA | -22.53% | -4.44% | |||
| EPS Basic | -91.11% | 23.71% | |||
| Normalized Basic EPS | -67.93% | -1.15% | |||
| EPS Diluted | -91.11% | 23.71% | |||
| Normalized Diluted EPS | -67.93% | -1.15% | |||
| Average Basic Shares Outstanding | -2.76% | -5.95% | |||
| Average Diluted Shares Outstanding | -2.62% | -5.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||